|
Post by silentknight on Jun 8, 2017 9:52:04 GMT -5
There's absolutely no reason to believe the numbers will be anything other than what we've seen for the last 18 months or so, i.e. 250 to 300.
For the sales team to be in the field this long with absolutely zero results has to be one of the biggest wastes of money that I've ever seen. The testimonials in the video may be inspiring, but it certainly isn't translating into sales and that's the only thing that matters.
Remember how excited we were when Rip accidentally posted monthly numbers as weekly? That's what I want to see, only legit this time. They are past due for numbers like that with reps in the field this long.
|
|
|
Post by slugworth008 on Jun 8, 2017 9:54:41 GMT -5
There's absolutely no reason to believe the numbers will be anything other than what we've seen for the last 18 months or so, i.e. 250 to 300. For the sales team to be in the field this long with absolutely zero results has to be one of the biggest wastes of money that I've ever seen. The testimonials in the video may be inspiring, but it certainly isn't translating into sales that that's the only thing that matters. As much as I hate to agree with you - I agree with you. Hopefully the sales team has been grinding away at the docs and endos and have begun wearing them down. Plus - if sales reps aren't selling they aren't getting commission checks and will move on to greener pastures.
|
|
|
Post by bones1026 on Jun 8, 2017 10:12:17 GMT -5
There's absolutely no reason to believe the numbers will be anything other than what we've seen for the last 18 months or so, i.e. 250 to 300. For the sales team to be in the field this long with absolutely zero results has to be one of the biggest wastes of money that I've ever seen. The testimonials in the video may be inspiring, but it certainly isn't translating into sales that that's the only thing that matters. As much as I hate to agree with you - I agree with you. Hopefully the sales team has been grinding away at the docs and endos and have begun wearing them down. Plus - if sales reps aren't selling they aren't getting commission checks and will move on to greener pastures. You can't get as many doctors as you want to prescribe, but if insurance companies aren't paying for it, your typical diabetic can't afford it on their own..insurance is in on this with BP..resolve that and you will see your spike in scripts..reps can't do anything about insurance
|
|
|
Post by silentknight on Jun 8, 2017 12:33:53 GMT -5
As much as I hate to agree with you - I agree with you. Hopefully the sales team has been grinding away at the docs and endos and have begun wearing them down. Plus - if sales reps aren't selling they aren't getting commission checks and will move on to greener pastures. You can't get as many doctors as you want to prescribe, but if insurance companies aren't paying for it, your typical diabetic can't afford it on their own..insurance is in on this with BP..resolve that and you will see your spike in scripts..reps can't do anything about insurance According to what MNKD's new CEO was saying earlier in the year, he certainly made it seem like many of the insurance hurdles had been solved. If that's not the case, then he certainly has some explaining to do. Personally, I think doctors, by and large, are reluctant to use it for whatever reason. Either way, the so called increases in scripts that management eluded to certainly haven't occurred and there's no reason to believe this week will be any different. I hope it is, but I'm not deluding myself that it will be.
|
|
|
Post by sportsrancho on Jun 8, 2017 14:02:50 GMT -5
There's absolutely no reason to believe the numbers will be anything other than what we've seen for the last 18 months or so, i.e. 250 to 300. For the sales team to be in the field this long with absolutely zero results has to be one of the biggest wastes of money that I've ever seen. The testimonials in the video may be inspiring, but it certainly isn't translating into sales that that's the only thing that matters. As much as I hate to agree with you - I agree with you. Hopefully the sales team has been grinding away at the docs and endos and have begun wearing them down. Plus - if sales reps aren't selling they aren't getting commission checks and will move on to greener pastures. It's time for a big jump. They should by this time cracked some of the doctors I would think. We need to get to the doctors that used to prescribe and get them back on board. I'm not sure if we have enough reps to get to them yet...
|
|
|
Post by ezmit on Jun 8, 2017 14:14:44 GMT -5
Towards the end of summer there needs to be a significant jump in scripts. It will happen imo.
|
|
|
Post by factspls88 on Jun 8, 2017 14:19:19 GMT -5
Does anyone know how many reps Sanofi had detailing Afrezza vs. the number of reps employed by Mannkind? If we knew it I don't recall. It would be interesting to see how many scripts have been generated per rep under Sanofi vs. under Mannkind, especially since it's likely, imo, that Mannkind had far fewer reps. Mike already alluded to cartridges per script trending higher.
|
|
|
Post by compound26 on Jun 8, 2017 14:24:06 GMT -5
Does anyone know how many reps Sanofi had detailing Afrezza vs. the number of reps employed by Mannkind? If we knew it I don't recall. It would be interesting to see how many scripts have been generated per rep under Sanofi vs. under Mannkind, especially since it's likely, imo, that Mannkind had far fewer reps. Mike already alluded to cartridges per script trending higher. Based on Mike's comments, we can assume it was about 4-5 hundred.
|
|
|
Post by factspls88 on Jun 8, 2017 14:29:12 GMT -5
Does anyone know how many reps Sanofi had detailing Afrezza vs. the number of reps employed by Mannkind? If we knew it I don't recall. It would be interesting to see how many scripts have been generated per rep under Sanofi vs. under Mannkind, especially since it's likely, imo, that Mannkind had far fewer reps. Mike already alluded to cartridges per script trending higher. Based on Mike's comments, we can assume it was about 4-5 hundred. What about Mannkind reps? The number 90 sticks in my head but I'm not sure. Anyone?
|
|
|
Post by standup on Jun 8, 2017 14:34:18 GMT -5
In hindsight it would appear a worthwhile strategy would have been to make sure each individual given a prescription received personal attention to make sure they successfully navigated the titration process. Each of those users would tell two friends and help them through the process and so on and so on. I believe exponential script growth would have resulted and the level of sales would far surpass where they are now. Thirty new scripts given 2 weeks to work out the kinks each tell 2 friends who take another 2 weeks and so on. After 12 weeks (1 Quarter) you'd be at 61,440 new scrips for that 2 week period. Add on the refills. Success isn't so elusive.
|
|
|
Post by wgreystone on Jun 8, 2017 15:03:02 GMT -5
There's absolutely no reason to believe the numbers will be anything other than what we've seen for the last 18 months or so, i.e. 250 to 300. For the sales team to be in the field this long with absolutely zero results has to be one of the biggest wastes of money that I've ever seen. The testimonials in the video may be inspiring, but it certainly isn't translating into sales that that's the only thing that matters. As much as I hate to agree with you - I agree with you. Hopefully the sales team has been grinding away at the docs and endos and have begun wearing them down. Plus - if sales reps aren't selling they aren't getting commission checks and will move on to greener pastures. I am pinning my hope on OneDrop collaboration. People who ordered OneDrop service are eager to manage their BG level. Afrezza would be an ideal tool for them to bring down BG spike. MNKD and OneDrop need to figure out how to bring Afrezza to these people cost effectively, maybe promote Afrezza as correction dose first? Can OneDrop figure out a way to prescribe Afrezza to those patients?
|
|
|
Post by compound26 on Jun 8, 2017 17:09:01 GMT -5
Based on Mike's comments, we can assume it was about 4-5 hundred. What about Mannkind reps? The number 90 sticks in my head but I'm not sure. Anyone? That's about right. I believe 85 is the number that was mentioned on last CC. Someone mentioned 95 the other day.
|
|
|
Post by agedhippie on Jun 8, 2017 17:49:56 GMT -5
As much as I hate to agree with you - I agree with you. Hopefully the sales team has been grinding away at the docs and endos and have begun wearing them down. Plus - if sales reps aren't selling they aren't getting commission checks and will move on to greener pastures. I am pinning my hope on OneDrop collaboration. People who ordered OneDrop service are eager to manage their BG level. Afrezza would be an ideal tool for them to bring down BG spike. MNKD and OneDrop need to figure out how to bring Afrezza to these people cost effectively, maybe promote Afrezza as correction dose first? Can OneDrop figure out a way to prescribe Afrezza to those patients? Second only to being forced to change your insulin the thing diabetics hate most is changing meters. Every meter has it's oddities and one you get used to them you don'r want to change. I even buy Bayer strips out of pocket rather than take the OneTouch Verio strips I can get via my insurance (Verio strips are garbage). The other thing they get attached to is lancets for the finger stick - I use Accu-Chek FastClix and MultiClix lancets and would never use the OneDrop lancet. For Type 2s who have never had a meter before the One Drop is a runner though. Probably most Type 1s wouldn't use it because they are already attached to a meter.
|
|
|
Post by sportsrancho on Jun 9, 2017 12:05:39 GMT -5
I saw the kids dad today. I had sent him the ASM video to watch. I also text him all the relevent things I can think of. ( Yes I do all the work:-)
Well he hadn't watched it. He asked me to just tell him the highlights.. same old same old right? he said. No I said, it's going to change your mind that there is a 40% chance of BK! He then asked me what the scripts were... I said I'm not talking to you about MNKD until you listen to that video! And I walked away and starting doing my own work-out. (He was already on the bike). I looked over and he had his phone and was watching:-)
He got so excited when Jeff starting talking he was downloading the One Drop App on another phone! He said, thank you so much for making me watch this!! Smiling from ear to ear through the whole thing:-) And very excited about our partnership with Jeff!
He said that Jake now has a Dexcom. And is now doing a follow up dose. 12 unit at the start of the meal. 4unit follow up. So he uses 40% more Afrezza now than before to stay in the zone and he feels incredible!
Jake also said that Tresiba makes things more even and it's easier to be aggressive with your first units of Afrezza.
|
|
|
Video ASM
Jun 10, 2017 23:13:47 GMT -5
via mobile
Post by straightly on Jun 10, 2017 23:13:47 GMT -5
I saw the kids dad today. I had sent him the ASM video to watch. I also text him all the relevent things I can think of. ( Yes I do all the work:-) Well he hadn't watched it. He asked me to just tell him the highlights.. same old same old right? he said. No I said, it's going to change your mind that there is a 40% chance of BK! He then asked me what the scripts were... I said I'm not talking to you about MNKD until you listen to that video! And I walked away and starting doing my own work-out. (He was already on the bike). I looked over and he had his phone and was watching:-) He got so excited when Jeff starting talking he was downloading the One Drop App on another phone! He said, thank you so much for making me watch this!! Smiling from ear to ear through the whole thing:-) And very excited about our partnership with Jeff! He said that Jake now has a Dexcom. And is now doing a follow up dose. 12 unit at the start of the meal. 4unit follow up. So he uses 40% more Afrezza now than before to stay in the zone and he feels incredible! Jake also said that Tresiba makes things more even and it's easier to be aggressive with your first units of Afrezza. So Sporty has a way to get ONE prescription. It was tough. But if our sales person does that once a week, our script count would have been somewhere totally different. Sporty, what does our sales guys miss? Does Mike know? Seriously, this just does not make sense.
|
|